Mental Health: U.S FDA Greenlights First-Ever Pill for Postpartum Depression
In a historic decision, the U.S. FDA has granted approval for the first oral medication designed to treat postpartum depression. This groundbreaking advancement offers hope to new mothers struggling with this often debilitating condition, providing them with a potential solution that could revolutionize postpartum care.

















